LND topic: arix-bioscience-plc page 1

arix bioscience plc

Flutter Entertainment Still Looks Good to Analysts

March 6, 2026

Jefferies analyst James Wheatcroft kept his “Buy” recommendation for Flutter Entertainment, setting a target of $210. 00 in a new report. The analyst focuses on the consumer‑cyclical market, covering companies such as Entain plc and The Gym. According to a data service, Wheatcroft’s past picks earne

science

Fast Lab Test Uses Microwave Plasma to Spot Drug Weaknesses

February 28, 2026

The safety of medicines can be hurt by light and heat, so scientists must test how drugs stand up to these forces. Traditional tools like HPLC, DSC and GC‑MS take time, need extra steps, and often look at light damage and heat damage separately. A new approach called microwave plasma torch mass spec

technology

New Cheap Sensor Detects THC in the Air

February 26, 2026

A fresh idea tackles a growing need. As more places allow cannabis use, people want to know how much THC is in the air. This new tool can help by spotting tiny amounts of the active compound. The sensor works differently from older gadgets. It uses a special screen‑printed graphene electrode that h

finance

Municipality Finance Raises €1 Billion in New Bonds

February 23, 2026

Municipality Finance Plc, one of Finland’s biggest credit firms, announced it will issue a €1 billion bond on 24 February 2026. The note matures on 14 June 2033 and pays a fixed interest rate of 2. 750% per year. The bond is part of a €50 billion debt‑raising plan that the company has been runnin

business

New Partners Hunt Breakthroughs for Kids With Rare Brain Disorders

February 23, 2026

Angelini Pharma and Quiver Bioscience have joined forces to look for new medicines that could help children suffering from hard‑to‑treat genetic epilepsies. The deal gives Quiver a chance to use Angelini’s long experience in brain drugs while Angelini gains access to Quiver’s cutting‑edge AI tools a

business

AMC Raises Money to Pay Off Old Debt and Refine Its Financing

February 23, 2026

AMC Entertainment, the world’s biggest movie theater chain, has begun a new private debt sale. A wholly‑owned unit called Muvico is offering $1. 73 billion in first‑lien notes that mature in 2031. These notes will be backed by AMC and its subsidiaries, which also back a new $750 million loan that th

health

Moderna’s New Flu Shot Hits a Roadblock

February 11, 2026

The U. S. Food and Drug Administration has decided not to review Moderna’s mRNA flu vaccine, even though the company spent years and millions of dollars on testing. The decision came after the agency’s chief vaccine regulator, Dr. Vinay Prasad, raised a concern. He said the trial used a compar

business

BioStem Technologies Expands Reach with BioTissue Acquisition

January 22, 2026

BioStem Technologies has just made a big move in the world of advanced wound care. They've bought the surgical and wound care business from BioTissue, a company known for its work in regenerative healing. This deal brings BioStem a whole new set of products, like Neox® and Clarix®, and a team of sal

finance

Finland's MuniFin Takes a Giant Leap in Global Finance

January 20, 2026

MuniFin, a major Finnish credit institution, has just made a significant move in the international financial market. They've issued a substantial USD 500 million benchmark under their MTN program. This isn't just any ordinary financial instrument. It's set to mature on 4 February 2030 and features a

opinion

Public Lands in Peril: A Year of Chaos and Controversy

January 13, 2026

The Trump administration's takeover brought swift and severe changes to public lands. The Department of the Interior saw a massive overhaul, with 2, 300 employees let go, leaving key agencies like the National Park Service and Bureau of Land Management (BLM) understaffed. This wasn't just about cutt